Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL

Andrew Macdonald1, David G Campbell, Rachel Toth

  • 1MRC Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK. a.macdonald@dundee.ac.uk

BMC Cell Biology
|January 13, 2006
PubMed
Abstract

Insights

Pim kinases phosphorylate the Bad protein at multiple sites, influencing its function and potentially inhibiting cell death. This research clarifies how Pim kinases interact with Bad, offering insights into cancer cell proliferation.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Pim kinases (Pim-1, 2, 3) are calcium/calmodulin-dependent protein kinases implicated in cancer.
  • Overexpression of Pim-1 and Pim-2 is linked to lymphoma development in mice.
  • Elevated Pim expression is observed in various human cancers.

Purpose of the Study:

  • To investigate the phosphorylation activity of Pim kinases on the Bcl-2 family member Bad.
  • To identify specific phosphorylation sites on Bad by Pim kinases.
  • To elucidate the functional consequences of Pim-mediated Bad phosphorylation.

Main Methods:

  • In vitro kinase assays using purified Pim kinases and Bad protein.
  • Expression of Pim kinases and Bad in HEK-293 cells.
  • Site-directed mutagenesis of Bad phosphorylation residues.
  • Analysis of Bad protein interactions with 14-3-3 and Bcl-XL.

Main Results:

  • Pim kinases constitutively phosphorylate Bad at Ser112, Ser136, and Ser155.
  • Pim-2 primarily phosphorylates Ser112; Pim-1 phosphorylates Ser112, Ser136, and Ser155; Pim-3 shows broader specificity, including Ser170.
  • Phosphorylation of Ser136 is crucial for subsequent phosphorylation of Ser112 and Ser155.
  • Pim phosphorylation promotes Bad binding to 14-3-3 and inhibits its association with Bcl-XL.

Conclusions:

  • All three Pim kinases phosphorylate Bad, primarily at Ser112, and multiple other sites.
  • Pim-mediated phosphorylation of Bad inhibits its pro-apoptotic function.
  • These findings support the role of Pim kinases in promoting cell proliferation and survival.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...